First FDA-Approved Study of Cord Blood to Treat Hearing Loss

Fri, 01/13/2012

HOUSTON -- January 12, 2012 -- Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss. View the press release.

Copyright © 2005- 2013 Hearing Loss Association of America®. All Rights Reserved.
The Hearing Loss Association of America (HLAA) is a tax-exempt, charitable organization and is eligible to receive tax deductible contributions under the IRS Code 501(c)(3).